Reuters logo
BRIEF-Ionis Pharma expects to end 2016 with pro forma net operating income in low to mid $20 mln range
January 6, 2017 / 9:40 PM / in 10 months

BRIEF-Ionis Pharma expects to end 2016 with pro forma net operating income in low to mid $20 mln range

Jan 6 (Reuters) - Ionis Pharmaceuticals Inc

* Ionis Pharmaceuticals significantly improves upon 2016 financial guidance

* Ionis Pharmaceuticals Inc says expects to end 2016 with pro forma net operating income in low to mid $20 million range and more than $650 million in cash

* Ionis Pharmaceuticals Inc - In 2016, generated more than $340 million in revenue, including more than $150 million in q4

* Ionis pharmaceuticals-In Q2 2017 co, GSK to announce phase 3 results from Neuro-TTR study with Ionis-TTR in patients with familial amyloid polyneuropathy Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below